Ionis Pharmaceuticals Inc (IONS) SEC News Oct. 29, 2025, 11:06 UTC 3 1 comments (30% Negative) IONIS PHARMACEUTICALS, INC. (IONS) Reports Q4 2025 Financial Results Comment Full text
Amarin Corporation Plc (AMRN) SEC News Oct. 29, 2025, 11:05 UTC 3 1 comments (30% Negative) AMARIN CORP PLC\UK (AMRN) Reports Q4 2025 Financial Results Comment Full text
Fulcrum Therapeutics (FULC) SEC News Oct. 29, 2025, 11:05 UTC 4 1 comments (90% Positive) Fulcrum Therapeutics, Inc. (FULC) Announces Enrollment Update for complete Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Avalo Therapeutics Inc. (AVTX) SEC News Oct. 29, 2025, 11:04 UTC 3 1 comments (70% Positive) AVALO THERAPEUTICS, INC. (AVTX) Announces Enrollment Update for expected Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Axogen Inc. (AXGN) SEC News Oct. 29, 2025, 11:03 UTC 3 1 comments (30% Negative) AXOGEN, INC. (AXGN) Reports Q4 2025 Financial Results Comment Full text
Bausch&Lomb Corp (BLCO) SEC News Oct. 29, 2025, 11:02 UTC 3 1 comments (30% Negative) Bausch & Lomb Corp (BLCO) Reports Q4 2025 Financial Results Comment Full text
Cabaletta Bio Inc (CABA) SEC News Oct. 29, 2025, 11:01 UTC 3 1 comments (80% Positive) CABALETTA BIO, INC. (CABA) Files Form 8-K Comment Full text
Tiziana Life Sciences Ltd. (TLSA) SEC News Oct. 29, 2025, 11:01 UTC 3 1 comments (85% Positive) Tiziana Life Sciences Ltd. (TLSA) Announces Clinical Development Update (Form 6-K) Comment Full text
OKYO Pharma (OKYO) SEC News Oct. 29, 2025, 11:00 UTC 3 1 comments (75% Positive) OKYO Pharma (OKYO) Files Form 6-K Comment Full text
Stepan Company (SCL) SEC News Oct. 29, 2025, 11:00 UTC 2 1 comments (10% Negative) STEPAN COMPANY (SCL) Reports Q4 2025 Financial Results Comment Full text